Drug Enforcement D-626-2013

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Status

Terminated

Classification

Class II

Report Date

July 10, 2013

Termination Date

June 18, 2015

Product Information

Product description
Heparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 2000 USP Units, Viaflex Plus Container, 1000mL, (NDC 0338-0433-04), b) Product code 2B0953: 1000 USP Units, Viaflex Plus Container, 500 mL (NDC 0338-0431-03), Baxter, Deerfield, IL 60015
Product quantity
N/A
Reason for recall
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide & Puerto Rico

Location & Firm

Recalling firm
Baxter Healthcare Corp.
Address
1 Baxter Pkwy, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-626-2013
Event ID
65288
Recall initiation date
May 21, 2013
Center classification date
June 28, 2013
Code info
Lot #: a) Product code 2B0944: N001164, Exp 7/13; b) Product code 2B0953: N001396, Exp 11/13
More code info
—